DocGo Inc.

DocGo Inc.

DCGO·NASDAQ

$0.57

-4.1%
HealthcareMedical - Care Facilities

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$56.73M
EPS-1.8400
P/E Ratio-0.31
Earnings Date08/06/2026
dcgo

DocGo Inc. Street Expectations Map

DCGO · NASDAQ

Wall Street analysts project that DCGO stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 5.84, with estimates ranging from a low of 1.50 to a high of 11.00.

Lowest Target
1.50
161.19%
Consensus Target
5.84
916.89%
Highest Target
11.00
1815.38%

The consensus 1-year price target stands at 5.84, with estimates ranging from a low of 1.50 to a high of 11.00.

Analyst Consensus Analysis

Upside Potential

+916.9%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

162.7% spread

High uncertainty. Very wide target spread indicates significant disagreement among analysts—major valuation uncertainty or transformation underway.

Analyst Conviction

Low

High uncertainty: Wide dispersion indicates analysts struggle to agree on valuation—proceed with caution and independent analysis.

Market Sentiment Insight

High risk, high reward: Substantial upside potential exists, but wide analyst disagreement signals execution risk or unclear catalysts. Thorough due diligence essential before committing capital.

dcgo

DocGo Inc. Forward Estimates of Revenue

DCGO · NASDAQ
Latest Revenue
322.20M
FY 2025
Avg Estimate
306.28M
FY 2026
Estimate Range
306.16M - 306.40M
Analyst Spread

Forward Growth Analysis

Projected Growth-4.9%

Declining expectations indicate headwinds—investigate whether temporary or structural issues.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

dcgo

DocGo Inc. Forward Estimates of Net Income

DCGO · NASDAQ
Latest Net Income
-182.40M
FY 2025
Avg Estimate
-33.42M
FY 2026
Estimate Range
-42.72M - -22.79M
Analyst Spread

Forward Growth Analysis

Projected Growth+81.7%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread60%

Wide estimate range reveals significant forecast uncertainty and potential volatility.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dcgo

DocGo Inc. Forward Estimates of EPS

DCGO · NASDAQ
Latest EPS
-1.84
FY 2025
Avg Estimate
$-0.34
FY 2026
Estimate Range
$-0.43 - $-0.23
Analyst Spread

Forward Growth Analysis

Projected Growth+81.3%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread58%

Wide estimate range reveals significant forecast uncertainty and potential volatility.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dcgo

DocGo Inc. Forward Estimates of EBIT

DCGO · NASDAQ
Latest EBIT
-89.16M
FY 2025
Avg Estimate
-5.54M
FY 2026
Estimate Range
-5.54M - -5.54M
Analyst Spread

Forward Growth Analysis

Projected Growth+93.8%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dcgo

DocGo Inc. Forward Estimates of EBITDA

DCGO · NASDAQ
Latest EBITDA
-73.50M
FY 2025
Avg Estimate
3.54M
FY 2026
Estimate Range
3.54M - 3.54M
Analyst Spread

Forward Growth Analysis

Projected Growth+104.8%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookStrong

Positive analyst consensus with strong growth expectations and forecast confidence.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dcgo

DocGo Inc. Forward Estimates of SG&A Expense

DCGO · NASDAQ
Latest SG&A Expense
158.69M
FY 2025
Avg Estimate
93.14M
FY 2026
Estimate Range
93.11M - 93.18M
Analyst Spread

Forward Growth Analysis

Projected Growth-41.3%

Significant contraction projected—major business challenges or industry disruption likely.

Analyst Coverage4 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread0%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dcgo

DocGo Inc. Insider Positioning

DCGO · NASDAQ

During the last 12 months, insiders have sold $72K worth of DCGO shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

17.1K

17.53K

Net Activity

-18K

-$18K

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

35.7K

54.33K

Net Activity

-54K

-$54K

Top Buyers

No buying activity

Top Sellers

1
BL

Bienstock Lee

Director, Officer: Chief Executive Officer

18.6K shares1 transactions

$28K

2
RN

Rosenberg Norman

Officer: Cfo And Treasurer

11.3K shares1 transactions

$17K

3
TED

Tendler Ely D

Director, Officer: General Counsel And Secretary

16.9K shares1 transactions

$15K

4
SS

Sugrue Stephen

Officer: Chief Compliance Officer

6.1K shares2 transactions

$11K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $72K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.